Capital Advisory Group Advisory Services’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-525
Closed -$37K 296
2022
Q1
$37K Buy
+525
New +$38.4K 0.02% 262
2021
Q4
Sell
-525
Closed -$50K 269
2021
Q3
$50K Hold
525
0.02% 262
2021
Q2
$65K Hold
525
0.02% 256
2021
Q1
$69K Hold
525
0.03% 231
2020
Q4
$70K Buy
+525
New +$63.5K 0.03% 230

Other funds holding EXAS

Capital Advisory Group Advisory Services's EXAS Position: Q2 2022 in Review

Capital Advisory Group Advisory Services sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 525 shares — an estimated $37K sold.

Capital Advisory Group Advisory Services first reported a position in EXAS in Q4 2020 and held it in 5 quarters. The position peaked at $70K in Q4 2020. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.

  • Capital Advisory Group Advisory Services reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
  • Capital Advisory Group Advisory Services sold 525 Exact Sciences shares in Q2 2022, an estimated $37K.
  • Capital Advisory Group Advisory Services first reported a position in Exact Sciences in Q4 2020 and held it in 5 quarters.
  • Capital Advisory Group Advisory Services's Exact Sciences position peaked at $70K in Q4 2020.
  • 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.

Based on Capital Advisory Group Advisory Services's 13F filing for Q2 2022, filed 12 Aug 2022.